Jimenez-Lucho V E, Saravolatz L D, Medeiros A A, Pohlod D
J Infect Dis. 1986 Jul;154(1):64-8. doi: 10.1093/infdis/154.1.64.
Despite optimal use of available antibacterial agents, endocarditis due to Pseudomonas aeruginosa is commonly associated with poor response to medical treatment. Two patients are described in whom emergence of resistance to beta-lactam antibiotics was associated with clinical failure. A subpopulation of resistant mutants (10(-7)) was found within the initial, apparently sensitive population of bacteria. These resistant mutants were similar to posttherapy isolates in their increased production of beta-lactamase and in their identical pattern of resistance to beta-lactam antibiotics. Moreover, the only beta-lactamase produced was type Id, and this enhanced production proved to be constitutive. A relatively large inoculum (10(6) colony-forming units/g of tissue) of bacteria was found postoperatively in the heart valves of both patients. The failure to respond is postulated to be due to the selection of these producers of high levels of beta-lactamase in a large bacterial inoculum.
尽管已对可用抗菌药物进行了优化使用,但铜绿假单胞菌引起的心内膜炎通常对药物治疗反应不佳。本文描述了两名患者,对β-内酰胺类抗生素产生耐药性与临床治疗失败相关。在最初看似敏感的细菌群体中发现了一个耐药突变亚群(10⁻⁷)。这些耐药突变体在β-内酰胺酶产量增加以及对β-内酰胺类抗生素的耐药模式相同方面与治疗后分离株相似。此外,产生的唯一β-内酰胺酶是Id型,且这种产量增加被证明是组成型的。两名患者的心脏瓣膜术后均发现相对大量的细菌接种物(10⁶菌落形成单位/克组织)。据推测,治疗无反应是由于在大量细菌接种物中选择了这些高水平β-内酰胺酶产生菌。